Evidence map›Paper›PMID 23847811›Full record

ArticleIET systems biology2013

Developing an in silico model of the modulation of base excision repair using methoxyamine for more targeted cancer therapeutics.

Evren Gurkan-Cavusoglu, Sriya Avadhani, Lili Liu, Timothy J Kinsella, Kenneth A Loparo

Open access · bronzeAbstract read
In one paragraph

Article in IET systems biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Evren Gurkan-CavusogluDepartment of Electrical Engineering and Computer Science, School of Engineering, Case Western Reserve University, 10900 Euclid Ave, Cleveland, OH 44106-7071, USA. exg44@case.edu
Sriya Avadhani
Lili Liu
Timothy J Kinsella
Kenneth A Loparo
Case Western Reserve University · USBrown University · US

Funding

Complex Systems &Control of MMR-Deficient CellsU56CA112963 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI LOPARO, KENNETH ALAN · 2004 to 2009
$2.7M
Modeling of DNA Mismatch Repair to Improve Cancer TherapeuticsR21CA140901 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI GURKAN-CAVUSOGLU, EVREN · 2009 to 2010
$380k
NCI NIH HHS R21 CA140901NCI NIH HHS U56 CA112963NCI NIH HHS U56CA112963
6 · The paper itself

Abstract

Base excision repair (BER) is a major DNA repair pathway involved in the processing of exogenous non-bulky base damages from certain classes of cancer chemotherapy drugs as well as ionising radiation (IR). Methoxyamine (MX) is a small molecule chemical inhibitor of BER that is shown to enhance chemotherapy and/or IR cytotoxicity in human cancers. In this study, the authors have analysed the inhibitory effect of MX on the BER pathway kinetics using a computational model of the repair pathway. The inhibitory effect of MX depends on the BER efficiency. The authors have generated variable efficiency groups using different sets of protein concentrations generated by Latin hypercube sampling, and they have clustered simulation results into high, medium and low efficiency repair groups. From analysis of the inhibitory effect of MX on each of the three groups, it is found that the inhibition is most effective for high efficiency BER, and least effective for low efficiency repair.

Indexed as

Models, BiologicalAnimalsAntineoplastic AgentsComputer SimulationDNA, NeoplasmDNA RepairDrug DesignDrug Therapy, Computer-AssistedHumansHydroxylaminesMolecular Targeted TherapyNeoplasmsAntineoplastic AgentsDNA, NeoplasmHydroxylaminesmethoxyamine

Identifiers

PMID23847811
PMCPMC3884826
OpenAlexW2014758166

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.